American College of Radiology guidelines for breast cancer screening

American Journal of Roentgenology

Volumn 171, Issue 1, 1998, Pages 29-33

  Feig, Stephen A ^a   D'Orsi, Carl J ^b   Hendrick, R Edward ^c   Jackson, Valerie P ^d   Kopans, Daniel B ^e   Monsees, Barbara ^f   Sickles, Edward A ^g   Stelling, Carol B ^h   Zinninger, Marie ⁱ   Wilcox Buchalla, Pamela ⁱ  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d INDIANA UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ AMERICAN COLLEGE OF RADIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; HUMAN; MAMMOGRAPHY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOLOGY; REVIEW;

EID: 0031859696     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.1.9648758     Document Type: Review

References (61)

1. The ACR and screening mammography: consensus and continued commitment. ACR Bull June 1997;53:4-9
2. Shapiro S. Screening: assessment of current studies. Cancer 1994;74:231-238
3. Feig SA. Methods to identify benefit from mammographic screening of women aged 40-49 years. Radiology 1996;200:309-316
4. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials 1993; February 25 (Doc. No. 32)
5. Hendrick RE, Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997; 22:87-92
6. Smart CR, Hendrick RE, Rutledge JH III, Smith RA. Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer 1995;75:1619-1626
7. Smart CR, Hendrick RE, Rutledge JH III, Smith RA. Erratum. Cancer 1995;75:2788
8. Falun meeting committee and collaborators. Falun meeting of breast cancer screening with mammography in women aged 40-49 years: report of the organizing committee and collaborators. Int J Cancer 1996;68:693-699
9. Larsson L-G, Andersson I, Bjurstam N, et al. Updated overview of the Swedish randomized trials on breast cancer screening wilh mammography: age groups 40-49 at randomization. Monogr Natl Cancer Inst 1997;22:57-62
10. Andersson I, Janzon L. Reduced breast cancer mortality in women under 50: updated results from the Malmo mammographic screening program. Monogr Natl Cancer Inst 1997;22:63-68
11. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997;80:2091-2099
12. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 with particular emphasis on the national breast screening study of Canada. Cancer 1994;74:1196-1203
13. Kopans DB. Screening for breast cancer and mortality reduction among women 40-49 years of age. Cancer 1994;74:311-322
14. Kopans DB, Feig SA. The Canadian national breast screening study: a critical review. AJR 1993; 161:755-760
15. Sickles EA, Kopans DB. Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst 1993;85:1621-1624
16. Feig SA. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995;75:2412-2419
17. De Koning HJ, Boer R, Warmerdam PG, Beemiterboer PMM, Vande Mass PJ. Quantitative interpretation of age-specific mortality reductions from Swedish breast cancer screening trials. J Natl Cancer Inst 1995;87:1217-1223
18. Smith RA. Screening women aged 40-49 years: where are we today? J Natl Cancer Inst 1995; 87:1198-1199
19. Tabar L, Duffy SW, Chen HH. Re: quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer screening trials. J Natl Cancer Inst 1996;88:52-53
20. Feig SA. Follow-up studies of the health insurance plan study and the breast cancer detection demonstration project screening trials in the USA. Recent Results Cancer Res 1990;119:39-53
21. Duffy SW, Day NE, Tabar L, Chen H-H, Smith TC. Markov models of breast tumor progression: some age-specific results. Monogr Natl Cancer Inst 1997;22:93-98
22. Curpen BN, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR 1995;164:1099-1103
23. Sickles EA, Ominsky SH, Sollitto RA, Galvin HB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990;175:323-327
24. Linver MN, Paster SB. Mammography outcomes in a practice setting by age: prognostic factors, sensitivity, and positive biopsy rate. Monogr Natl Cancer Inst 1997;22:113-118
25. Kopans DB, Moore RH, McCarthy KA, et al. Positive predictive value of breast biopsy performed as result of mammography: there is no abrupt change at age 50 years. Radiology 1996;200:357-360
26. Bassett LW, Liu TH, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR 1991; 157:21-24
27. Page DC, Jensen RA. Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. JAMA 1996;275:948-949
28. Joensu H, Klemi PJ, Tuominen J, Rasomen O, Parvinen I. Breast cancer found at screening and previous detection by women themselves (letter). Lancet 1992;339:315
29. Feig SA. Mammographic screening of women aged 40-49 years: benefit, risk, and cost considerations. Cancer 1995;76:2097-2106
30. Metller FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RO, Linver MN. Benefits versus risks from mammography: a critical reassessment. Cancer 1996;77:903-909
31. Feig SA. Assessment of radiation risk from screening mammography. Cancer 1996;77:818-822
32. Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. Monogr Natl Cancer Inst 1997;22:119-124
33. Tabar L, Fagerberg G, Chen H-H, et al. Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 1995; 75:2507-2517
34. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161: 37-41
35. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987;55:547-551
36. Feig SA. Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years. Radiology 1994;193: 311-314
37. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-38
38. Feig SA. Strategies for improving sensitivity of screening mammography for women aged 40-49 years. JAMA 1996;276:73-74
39. Feig SA. Increased benefit from shorter mammography screening intervals for women ages 40-49 years. Cancer 1997;80:2035-2039
40. Lindfors KK, Rosenquist J. The cost-effectiveness of mammographic screening strategies. JAMA 1995;274:881-884
41. Rosenquist CJ, Lindfors KK. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology 1994;191:647-650
42. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER cancer statistics review, 1973-1994. Bethesda, MD: National Cancer Institute, 1997:124. NIH publication 97-2789
43. American Cancer Society. Breast cancer facts and figures, 1997. Atlanta: American Cancer Society, 1997:1
44. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the health insurance plan project and its sequelae. Baltimore: Johns Hopkins, 1988:13
45. Kelsey JL, Gammon M. The epidemiology of breast cancer. CA Cancer J Clin 1991;41:146-165
46. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886
47. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273:577-585
48. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-151
49. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 1996;78:1024-1034
50. Streuwing JP, Hange P, Wacholder S, et al. The risk of cancer associated with specific mutation of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-1408
51. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-695
52. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment for Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31
53. Seidman H, Stellman S, Mushinski MH. A different perspective on breast cancer risk factors: some implications of the nonattributable risk. CA Cancer J Clin 1982;32:301-313
54. Vogel VG, Yeomans A, Higginbotham E. Clinical management of women at increased risk for breast cancer. Breast Cancer Res Treat 1993; 28:195-210
55. Burke W, Daly M, Garber J, et al. for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA 1 and BRCA 2. JAMA 1997;277:997-1003
56. Gastrin G, Miller AB, To T, et al. Incidence and mortality from breast cancer in the MAMA program for breast screening in Finland, 1973-1986. Cancer 1994;73:2168-2174
57. Baker LH. Breast cancer detection demonstration project: five-year summary report. CA Cancer J Clin 1982;32: 194-225
58. Costanza ME. Breast cancer screening in older women: synopsis of a forum. Cancer 1992;69: 1925-1931
59. Feig SA. Mammographic screening of elderly women (answer to question). JAMA 1996; 276:446
60. O'Mallay MS, Fletcher SW. Screening for breast cancer with breast self-examination: a critical review. JAMA 1987;257:2197-2203
61. Foster RS, Worden JK, Costanza MC, Solomen LJ. Clinical breast examination and breast self-examination: past and present effect on breast cancer survival. Cancer 1992;69:1992-1998